Humana Inc HUM Stock Analysis
- NYSE
- Stock
- Market closed · opens Monday 9:30 AM ET
$433.74 up $21.95, 5.33% at close Nov 6
Last close · Previous close $411.79
- Market cap
- $52.08BAt the Nov 6 close
- P/E ratio
- 40.96On last 12 months’ EPS
- Diluted EPS
- $10.59Last 12 months
- Dividend yield
- 0.82%Last 12 months
Price chart
$433.74up $21.95, 5.33%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$411.79Nov 5
- Volume2.58MNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume1.58MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $163.11 to $456.50; now $433.74
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
HUM beat the S&P 500 in 4 of 7 periods.
| Period | HUM and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | HUM: up 7.5% S&P 500: down 5.6% | HUM beat the S&P 500 by 13.1 percentage points Beat |
| 3M | HUM: up 18.4% S&P 500: down 4.1% | HUM beat the S&P 500 by 22.5 percentage points Beat |
| YTD | HUM: up 71.0% S&P 500: up 8.7% | HUM beat the S&P 500 by 62.3 percentage points Beat |
| 1Y | HUM: up 75.0% S&P 500: up 10.9% | HUM beat the S&P 500 by 64.1 percentage points Beat |
| Long term | ||
| 3Y | HUM: down 7.7% S&P 500: up 75.0% −2.6% vs +20.5% a year | HUM trailed the S&P 500 by 82.7 percentage points Trailed |
| 5Y | HUM: up 0.6% S&P 500: up 67.8% +0.1% vs +10.9% a year | HUM trailed the S&P 500 by 67.2 percentage points Trailed |
| 10Y | HUM: up 182.0% S&P 500: up 313.1% +10.9% vs +15.2% a year | HUM trailed the S&P 500 by 131.1 percentage points Trailed |
$10,000 invested in HUM 10 years ago (Nov 4, 2016) would be worth about $28,205 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
HUM beat the S&P 500 in 4 of 7 periods.
| Period | HUM and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | HUM: up 7.3% S&P 500: down 5.6% | HUM beat the S&P 500 by 12.9 percentage points Beat |
| 3M | HUM: up 18.1% S&P 500: down 4.3% | HUM beat the S&P 500 by 22.4 percentage points Beat |
| YTD | HUM: up 69.3% S&P 500: up 7.8% | HUM beat the S&P 500 by 61.5 percentage points Beat |
| 1Y | HUM: up 72.7% S&P 500: up 9.7% | HUM beat the S&P 500 by 63.0 percentage points Beat |
| Long term | ||
| 3Y | HUM: down 11.0% S&P 500: up 68.8% −3.8% vs +19.1% a year | HUM trailed the S&P 500 by 79.8 percentage points Trailed |
| 5Y | HUM: down 4.3% S&P 500: up 56.9% −0.9% vs +9.4% a year | HUM trailed the S&P 500 by 61.2 percentage points Trailed |
| 10Y | HUM: up 159.1% S&P 500: up 252.6% +10.0% vs +13.4% a year | HUM trailed the S&P 500 by 93.5 percentage points Trailed |
$10,000 invested in HUM 10 years ago (Nov 4, 2016) would be worth about $25,907 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$563.00
Closing high on . Now 23.0% below that record.
Split-adjusted daily closes since Dec 31, 1981.
Stock splits
HUM hasn’t split since its price history begins in 1981.
Valuation
The Nov 6 close compared with the last 12 months of reported results (the four quarters to Jun 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
41.0×The Nov 6 close ÷ diluted EPS over the last 12 months ($10.59)
The range covers daily P/E ratios from Oct 28, 2021 to Nov 6, 2026, each based on the previous 12 months of earnings.
HUM trades at 41.0× its earnings over the last 12 months, above its 5-year median of 21.3×. In plain terms, buyers are paying about $41 for each $1 of profit from the past year. How to read P/E
Other valuation measures
- 0.4×Last 12 months’ revenue
Market value divided by revenue over the last 12 months. Useful when earnings are small or negative.
P/S = Market cap ÷ Revenue (last 12 months)Price-to-sales ratio - 2.7×Book value as of Jun 30, 2026
Price relative to accounting equity (book value) per share on the Jun 30, 2026 balance sheet. Asset-light companies often trade far above book value.
P/B = Price ÷ Book value per sharePrice-to-book ratio - 14.0×Last 12 months’ EBITDA
Enterprise value divided by EBITDA over the last 12 months. It compares companies with different amounts of debt.
EV/EBITDA = Enterprise value ÷ EBITDA (last 12 months)EV/EBITDA explained - 3.79%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $42.80BAt the Nov 6 close
What it would cost to buy the whole business: the market cap at the Nov 6 close, plus debt, minus cash and short-term investments from the Jun 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own HUM DCF in Excel. Value Humana with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $145.68Bup 18.3%
- Net income
- $1.28Bdown 18.8%
- Diluted EPS
- $10.59down 18.9%
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $29.40B | $480.00M | $3.98 |
| Q4 FY24 (Dec 31, 2024) | $29.21B | −$693.00M | −$5.74 |
| Q1 FY25 (Mar 31, 2025) | $32.11B | $1.24B | $10.30 |
| Q2 FY25 (Jun 30, 2025) | $32.39B | $545.00M | $4.51 |
| Q3 FY25 (Sep 30, 2025) | $32.65B | $195.00M | $1.62 |
| Q4 FY25 (Dec 31, 2025) | $32.52B | −$796.00M | −$6.59 |
| Q1 FY26 (Mar 31, 2026) | $39.65B | $1.19B | $9.83 |
| Q2 FY26 (Jun 30, 2026) | $40.87B | $694.00M | $5.73 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $83.06B | $2.93B | $22.67 |
| FY22 (Dec 31, 2022) | $92.87B | $2.81B | $22.08 |
| FY23 (Dec 31, 2023) | $106.37B | $2.49B | $20.00 |
| FY24 (Dec 31, 2024) | $117.76B | $1.21B | $9.98 |
| FY25 (Dec 31, 2025) | $129.66B | $1.19B | $9.84 |
Margins
- Gross 13.7%
- Operating 1.9%
- Net 0.9%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $1.97BLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$2.54BLast 12 months
- Capital spending$567.00MLast 12 months
- 1.4%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $150.00MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$430.00MLast 12 months
- Total returned$580.00MLast 12 months
29% of free cash flow
Balance sheet
- $25.15BAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$14.60BAs of Jun 30, 2026
- Net cash$10.55BAs of Jun 30, 2026
- 1.74As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.76As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 6 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✓Operating cash flow was positive: passed
- ✗Return on assets improved: not passed
- ✓Operating cash flow exceeded net income: passed
- ✓Long-term debt fell relative to assets: passed
- ✗Current ratio improved: not passed
- ✓Share count didn’t rise: passed
- ✗Gross margin improved: not passed
- ✓Asset turnover (revenue ÷ assets) improved: passed
- 6.9%Last 12 months
Over the last 12 months, Humana’s net income was 6.9% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 2.4%Last 12 months
Over the last 12 months, Humana’s net income was 2.4% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $0.87 |
| 2017 | $1.89 |
| 2018 | $2.00 |
| 2019 | $2.20 |
| 2020 | $2.50 |
| 2021 | $2.80 |
| 2022 | $3.15 |
| 2023 | $3.54 |
| 2024 | $3.54 |
| 2025 | $3.54 |
| 2026 (to date) | $2.66 |
Dividend details
- $3.54Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- 0.82%; 5-yr low 0.48%, 5-yr high 2.67%Last 12 months
Dividends paid over the last 12 months as a share of the Nov 6 close. The bar shows where that yield sits in its range over the past five years; the median was 0.92%.
- $0.89Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
- FrequencyQuarterly4 payments in the last 12 months
- up 7.2% a yearFull years 2020–2025
The compound annual growth rate of the full-year dividend per share from 2020 to 2025.
- 33.4%Last 12 months
The share of earnings paid out as dividends over the last 12 months. Lower ratios leave more room to reinvest or raise the dividend.
Payout = Dividends per share ÷ Diluted EPS (both last 12 months)Payout ratio calculator
About Humana Inc
Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Headquarters
- Kentucky, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- NYSE
- Asset type
- Common stock
- Price history since
HUM news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
HUM stock FAQ
What is HUM stock’s price today?
Humana (HUM) traded at $433.74 at the close on , up $21.95 (5.33%) from the previous close of $411.79. Over the past 52 weeks it has traded between $163.11 and $456.50.
If you invested $1,000 in HUM 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in HUM on would be worth about $2,820 at the close on , a total return of +182.0%. The same $1,000 would be worth $1,006 if invested five years ago, $1,750 if invested one year ago, $8,529 if invested 20 years ago, and $28,111 if invested 30 years ago. Past performance doesn’t predict future returns.
What is Humana’s market cap?
Humana’s market capitalization is about $52.1 billion. That’s Tiingo’s daily market cap for , at that day’s closing price of $433.74 (how market cap works). Humana reported 120.06M shares outstanding at the end of its latest quarter ().
What is HUM’s P/E ratio?
HUM trades at 41.0 times its diluted earnings over the four quarters to ($10.59 per share), at the close. Over the past five years its P/E has ranged from 15.7 to 41.5, with a median of 21.3. (How the P/E ratio works.)
How much revenue does Humana make?
Humana reported $145.7 billion of revenue over the four quarters to , up 18.3% from the twelve months before. In its latest quarter (Q2 FY26, ended ) revenue was $40.9 billion, up 26.2% from a year earlier.
Is Humana profitable?
Yes. Humana earned $1.3 billion of net income over the four quarters to , a net margin of 0.9%, and its operating margin was 1.9% (what margins tell you).
What are HUM’s earnings per share?
HUM’s diluted earnings per share were $10.59 over the four quarters to , compared with $13.05 in the twelve months before. The latest quarter (Q2 FY26) brought $5.73 per share, against $4.51 a year earlier (how EPS works).
Does HUM pay a dividend?
Yes. Humana pays a quarterly dividend. The most recent was $0.89 per share, with an ex-dividend date of . Over the last twelve months it paid $3.54 per share, a 0.82% yield at the close (how dividend yield works).
Based on the last 12 months’ payments ($3.54 per share), and if the next 12 months match the last 12, 100 shares would receive about $354 over 12 months, and $1,000 over 12 months would take about 283 shares, roughly $122,748 at the close. Dividends can change.
What is HUM’s 52-week high and low?
Over the past 52 weeks HUM has traded as low as $163.11 and as high as $456.50. At $433.74 at the close on , it is 5.0% below that high and 165.9% above the low.
What is HUM’s all-time high?
HUM’s highest closing price was $563.00 on , adjusted for stock splits. At $433.74 at the close on , it is 23.0% below that record.
Has HUM stock ever split?
No. HUM hasn’t split since its price history begins in 1981.
How has HUM stock performed?
Including dividends and measured to the close on , HUM has returned +71.0% so far this year and +75.0% over the past year, and +0.6% over five years (+0.1% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is Humana in?
Humana is in the Healthcare sector and the Healthcare Plans industry, and is headquartered in Kentucky, USA.
What exchange does HUM trade on?
Humana trades on the NYSE under the ticker symbol HUM. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.